Latest News

STAT Plus: Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that predictable routine of Zoom meetings, Skype meetings, and deadlines has returned. Pandemic or no pandemic, the world somehow keeps spinning. So let us embrace the inevitable together with a comforting cup of stimulation and proceed on the journey. Toward that end, here are a few tidbits. Hope your day goes well, and do keep in touch. …

Two Covid-19 vaccine candidates being developed by Pfizer (PFE) and BioNTech (BNTX) received Fast Track designation status from the Food and Drug Administration, Reuters writes. The vaccines are the most advanced of at least four vaccines being assessed by the companies in ongoing trials in the U.S. and Germany. Earlier this month, the companies disclosed that one vaccine, called BNT162b1, showed potential against the virus and was found to be well-tolerated in early-stage human trials. Early data from the German trial of the same vaccine are expected this month.

Continue to STAT Plus to read the full story…

Source link

Related posts

Medical News Today: Brain study shows why mindfulness eases pain


Where did they go? Millions left city before quarantine


FeetMe Partners with Novartis to Study Gait of MS Patients: Interview with CEO Alexis Mathieu


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World